Figure 2From: Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemiaOverall survival for total sample in Bu/Cy and t-IV Bu/Flu groups (log-rank p = 0.0356).Back to article page